Elsevier Inc.

SHERPA: Unknown

People

  1. Park
    Park
  2. Sadelain
    Sadelain
  3. Wang
    Wang
  4. Abdel-Wahab
    Abdel-Wahab
  5. Devlin
    Devlin
  6. Dogan
    Dogan
  7. Geyer
    Geyer
  8. Kelly
    Kelly
  9. Monette
    Monette
  10. Mukherjee
    Mukherjee

Groups

  1. Adult Leukemia (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Hematologic Malignancies Research (5)
  6. Hematologic Malignancies, Division of (5)
  7. Sloan Kettering Institute Faculty (4)
  8. Molecular Pharmacology and Chemistry Program Faculty (3)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  10. Alumni (GSK) (1)
Search Within
  1. "Clinical Lymphoma, Myeloma and Leukemia"
  2. "Renier Brentjens"
Formats
  1. Meeting Abstract (5)
Groups
  1. Adult Leukemia (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Hematologic Malignancies Research (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Renier Brentjens (5)
  2. Brigitte Senechal (2)
  3. Isabelle Riviere (2)
  4. Jae Park (2)
  5. Joseph Jurcic (2)
  6. Mark Frattini (2)

More People

Years
  1. 2022 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (2)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
    Meeting Abstract

    Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Next generation chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Targeting the cell cycle regulated CDC7 kinase pathway as a novel therapeutic approach for hematologic malignancies
    Meeting Abstract

    Santos, R.; Shum, D.; Churchill, M.; Mukherjee, S.; Brentjens, R. J.; Jurcic, J. G.; Kelly, T.; Djaballah, H.; Frattini, M. G.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save